Fig. 3From: Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studiesAdverse clinical outcomes associated with a short versus prolonged DAPT use in patients with DM (part 2)Back to article page